Michael Wirth
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in ⓘ
-
- Advanced Drug Delivery Systems 16
- Advancements in Transdermal Drug Delivery 9
- Urology 11
- Urinary Bladder and Prostate Research 8
- Co-authors
- Franz Gabor (75 shared papers)Claudia Valenta (10 shared papers)Stefan Toegel (9 shared papers)Helmut Viernstein (9 shared papers)Lukas Neutsch (10 shared papers)Fritz Pittner (6 shared papers)Winfried Neuhaus (8 shared papers)Christian R. Noe (7 shared papers)
- Journals
- International Journal of Pharmaceutics (13 papers)Journal of Controlled Release (10 papers)European Journal of Pharmaceutics and Biopharmaceutics (10 papers)Pharmaceutical Research (5 papers)Journal of drug targeting (3 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michael Wirth
116 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 132
- Pharmaceutical Science 679
- Biomaterials 526
- Neurology 152
- Biotechnology 151
- Molecular Medicine 86
Countries citing papers authored by Michael Wirth
This map shows the geographic impact of Michael Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wirth more than expected).
Fields of papers citing papers by Michael Wirth
This network shows the impact of papers produced by Michael Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wirth. The network helps show where Michael Wirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 201 | |
| 2 | 2002 | 111 | |
| 3 | 1999 | 82 | |
| 4 | 2006 | 81 | |
| 5 | 2004 | 81 | |
| 6 | 2010 | 74 | |
| 7 | 1998 | 72 | |
| 8 | 1988 | 69 | |
| 9 | 1998 | 68 | |
| 10 | 2003 | 67 | |
| 11 | 1995 | 66 | |
| 12 | 2002 | 65 | |
| 13 | 2007 | 58 | |
| 14 | 2004 | 55 | |
| 15 | 2013 | 51 | |
| 16 | 2004 | 50 | |
| 17 | 2000 | 49 | |
| 18 | 2011 | 48 | |
| 19 | 2008 | 47 | |
| 20 | 1997 | 46 |
About Michael Wirth
Michael Wirth is a scholar working on Pharmaceutical Science, Urology, Biotechnology, Endocrinology and Neurology, having authored 117 papers that have together received 2.9k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (16 papers), Glycosylation and Glycoproteins Research (15 papers), Bladder and Urothelial Cancer Treatments (12 papers), Nanoparticle-Based Drug Delivery (9 papers), Advancements in Transdermal Drug Delivery (9 papers), Microfluidic and Bio-sensing Technologies (9 papers), Urinary Bladder and Prostate Research (8 papers) and Transgenic Plants and Applications (8 papers). The work is most often cited by research in Pharmaceutical Science (679 citations), Biomaterials (526 citations), Neurology (152 citations), Biotechnology (151 citations) and Molecular Medicine (86 citations). Michael Wirth has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Franz Gabor, Claudia Valenta, Stefan Toegel, Helmut Viernstein, Lukas Neutsch, Fritz Pittner, Winfried Neuhaus, Christian R. Noe, M.A Arangoa and Juan M. Irache. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Controlled Release, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.